Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pemphigus Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07641725
What this trial is testing

Comparison of the Efficacy of Clobetasol Propionate 0.05% Mouthwash, Photobiomodulation, and Their Combination in Managing of Oral Lesions in Patient With Pemphigus Vulgaris.

Who this might be right for
Oral Lesions in Patients With Pemphigus Vulgaris
Damascus University 30
Very early researchNot Yet RecruitingNCT07769333
What this trial is testing

Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus Vulgaris

Who this might be right for
Pemphigus VulgarisRituximab (RTx)
Khyber Teaching Hospital 92
Very early researchEnded earlyNCT01313923
What this trial is testing

Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus

Who this might be right for
Pemphigus
University of California, Irvine 3
Testing effectiveness (Phase 2)Study completedNCT00135720
What this trial is testing

Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Massachusetts General Hospital 12
Testing effectiveness (Phase 2)Study completedNCT02704429
What this trial is testing

PRN1008 in Adult Patients With Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Principia Biopharma, a Sanofi Company 42
Large-scale testing (Phase 3)Study completedNCT01299857
What this trial is testing

Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab

Who this might be right for
Pemphigus
University Hospital, Rouen 22
Large-scale testing (Phase 3)Study completedNCT04598451
What this trial is testing

Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 222
Not applicableLooking for participantsNCT07681388
What this trial is testing

CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Jinbo Chen 3
Not applicableNot Yet RecruitingNCT06863454
What this trial is testing

Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation.

Who this might be right for
Pemphigus Vulgaris (PV)
Assiut University 62
Post-approval studies (Phase 4)UnknownNCT05303272
What this trial is testing

Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)

Who this might be right for
Pemphigus Vulgaris
Tongji Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT01920477
What this trial is testing

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Novartis Pharmaceuticals 35
Testing effectiveness (Phase 2)Looking for participantsNCT04422912
What this trial is testing

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

Who this might be right for
Pemphigus Vulgaris
Cabaletta Bio 40
Not applicableUnknownNCT05992727
What this trial is testing

Evaluation of Galectin-3 in Serum and Saliva of Pemphigus Patients

Who this might be right for
Galectin-3 and Pemphigus
Assiut University 60
Not applicableStudy completedNCT00960713
What this trial is testing

The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

Who this might be right for
PemphigusAuto-immune Thrombocytopenic PurpuraHemolytic Auto-immune Anaemia+2 more
University Hospital, Toulouse 35
Large-scale testing (Phase 3)Study completedNCT02383589
What this trial is testing

Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)

Who this might be right for
Pemphigus Vulgaris
Hoffmann-La Roche 135
Not applicableStudy completedNCT06167408
What this trial is testing

Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients

Who this might be right for
Pemphigus Vulgaris
First Affiliated Hospital of Chongqing Medical University 96
Testing effectiveness (Phase 2)WithdrawnNCT03780166
What this trial is testing

The Safety and Tolerability of INCB050465 in Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Incyte Corporation
Not applicableStudy completedNCT04724733
What this trial is testing

Promoting Risk Reduction Among Young Adults With Asthma During Wildfire Smoke Events (TRAK)

Who this might be right for
Asthma
Washington State University 67
Large-scale testing (Phase 3)UnknownNCT01974518
What this trial is testing

Comparative Study of Rituximab Versus Combination of Rituximab and Intravenous Cyclophosphamide in Severe Pemphigus

Who this might be right for
Pemphigus
Uprety Shraddha 20
Not applicableStudy completedNCT00074685
What this trial is testing

National Registry for Ichthyosis and Related Disorders

Who this might be right for
Darier DiseaseHailey-Hailey DiseaseHyperkeratosis, Epidermolytic+4 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 610
Next Page